The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Skin cancer is the most common other primary cancer in patients with lymphoma. However, an intriguing association between cutaneous lymphoma and other primary cancers has been suggested in a few studies. Objective: This study investigated other primary cancers in patients with cutaneous lymphoma to evaluate the risk for occurrence of each type of cancer. Methods: We screened for other primary cancers in 428 patients with cutaneous lymphoma. Clinical features were analyzed according to the lineage and origin of the lymphomas. We calculated the standardized incidence ratio with statistical analysis for each group according to age. Results: Among 330 patients with cutaneous T cell lymphoma and 98 with cutaneous B cell lymphoma, a total of 43 cancers in 38 patients were finally included. Other primary cancers were prevalent in patients with cutaneous B cell lymphoma and patients with secondary cutaneous lymphoma. However, those differences were not significant when the age was calibrated by multiple logistic regression. Metachronously higher standardized incidence ratios were observed for primary lung (standardized incidence ratio [SIR], 14.81; 95% confidence interval [CI], 3.05∼39.54), skin (SIR, 68.05; 95% CI, 14.03∼181.62), and breast (SIR, 12.91; 95% CI, 1.56∼41.41) cancers with statistical significance. Conclusion: Other primary cancers more preferentially occurred in patients with cutaneous lymphoma. Clinicians should carefully examine patients with cutaneous lymphoma for other cancers, especially lung, skin, and breast cancers.
Abstract
Background: Skin cancer is the most common other primary cancer in patients with lymphoma. However, an intriguing association between cutaneous lymphoma and other primary cancers has been suggested in a few studies. Objective: This study investigated other primary cancers in patients with cutaneous lymphoma to evaluate the risk for occurrence of each type of cancer. Methods: We screened for other primary cancers in 428 patients with cutaneous lymphoma. Clinical features were analyzed according to the lineage and origin of the lymphomas. We calculated the standardized incidence ratio with statistical analysis for each group according to age. Results: Among 330 patients with cutaneous T cell lymphoma and 98 with cutaneous B cell lymphoma, a total of 43 cancers in 38 patients were finally included. Other primary cancers were prevalent in patients with cutaneous B cell lymphoma and patients with secondary cutaneous lymphoma. However, those differences were not significant when the age was calibrated by multiple logistic regression. Metachronously higher standardized incidence ratios were observed for primary lung (standardized incidence ratio [SIR], 14.81; 95% confidence interval [CI], 3.05∼39.54), skin (SIR, 68.05; 95% CI, 14.03∼181.62), and breast (SIR, 12.91; 95% CI, 1.56∼41.41) cancers with statistical significance. Conclusion: Other primary cancers more preferentially occurred in patients with cutaneous lymphoma. Clinicians should carefully examine patients with cutaneous lymphoma for other cancers, especially lung, skin, and breast cancers.
참고문헌 (22)
- Lee JH, "Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea", Clin Exp Dermatol, 38, pp.457~463 (2013)[DOI]
- Jenni D, "Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre", Br J Dermatol, 164, pp.1071~1077 (2011)[DOI]
- Lee WJ, "Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage", Br J Dermatol, 173, pp.134~145 (2015)[DOI]
- Amber KT, "Second primary malignancies in CTCL patients from 1992 to 2011: a SEER-based, population-based study evaluating time from CTCL diagnosis, age, sex, stage, and CD30+ subtype", Am J Clin Dermatol, 17, pp.71~77 (2016)[DOI]
- Huang KP, "Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts", Arch Dermatol, 143, pp.45~50 (2007)
- Scarisbrick JJ, "Secondary malignant neoplasms in 71 patients with Sezary syndrome", Arch Dermatol, 135, pp.1381~1385 (1999)
- Kantor AF, "Risk of second malignancy after cutaneous T-cell lymphoma", Cancer, 63, pp.1612~1615 (1989)[DOI]
- Brownell I, "Increased malignancy risk in the cutaneous T-cell lymphoma patient population", Clin Lymphoma Myeloma, 8, pp.100~105 (2008)[DOI]
- Olsen EA, "Second malignancies in cutaneous T cell lymphoma", J Am Acad Dermatol, 10, pp.197~204 (1984)[DOI]
- Chan SA, "Primary cutaneous B-cell lymphoma: systemic spread is rare while cutaneous relapses and secondary malignancies are frequent", Br J Dermatol, 177, pp.287~289 (2017)[DOI]
- Bae SH, "Other primary systemic cancers in patients with melanoma: analysis of balanced acral and nonacral melanomas", J Am Acad Dermatol, 74, pp.333~340 (2016)[DOI]
- Breslow NE, "Statistical methods in cancer research", IARC Sci Publ, (82), pp.1~406 (1987)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014", Cancer Research and Treatment, 49(2), pp.292~305 (2017), 대한암학회
- Vakeva L, "Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma", J Invest Dermatol, 115, pp.62~65 (2000)[DOI]
- Lee BN, "Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma", Clin Diagn Lab Immunol, 6, pp.79~84 (1999)
- Rook AH, "IL-12 reverses cytokine and immune abnormalities in Sezary syndrome", J Immunol, 154, pp.1491~1498 (1995)
- Thestrup-Pedersen K, "Cutaneous T-cell lymphoma. A hypothesis on disease pathophysiology involving deficiency in DNA repair", J Eur Acad Dermatol Venereol, 30, pp.1682~1685 (2016)[DOI]
- Alshareeda AT, "Clinicopathological significance of KU70", KU80, a key DNA damage repair protein in breast cancer, 2013, pp.139, 301~310
- Ferenczi K, "Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70", Br J Dermatol, 163, pp.564~571 (2010)[DOI]
- Tseng RC, "Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study", Cancer, 115, pp.2939~2948 (2009)[DOI]
- Azad Kumar, "Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival", 대한암예방학회지, 21(4), pp.227~234 (2016), 대한암예방학회[DOI]
- Feehan RP, "Molecular signaling cascades involved in nonmelanoma skin carcinogenesis", Biochem J, 473, pp.2973~2994 (2016)[DOI]